FOIA March Madness 2018 - Agency Talking Points (November 8, 2016 - March 13, 2018) (Food and Drug Administration)

Beryl Lipton filed this request with the Food and Drug Administration of the United States of America.
Tracking #

2018-2483

Multi Request FOIA March Madness 2018 - Agency Talking Points (November 8, 2016 - March 13, 2018)
Status
Completed
Tags

Communications

From: Beryl Lipton

To Whom It May Concern:

This is a request under the Freedom of Information Act. I hereby request the following records:

For the 16-month, 5-day period from Tuesday, November 8, 2016 through Tuesday, March 13, 2018:

(SUMMARY)

Any and all talking points and similar memorandums, emails, and transcripts providing advice or direction on how to handle the media, media interviews, and statements.

----
(SPECIFICALLY)

Please include in your responsive materials any documents, emails, or communications with the following phrases in the title or subject line:

TALKING POINTS
STMT
STATEMENT
PRESS STRATEGY
___________

It would be greatly appreciated if materials could be provided on a rolling basis.

1. In the Office of Public Affairs or equivalent division

Please provide first all such materials produced in this agency’s Office of Public Affairs or equivalent division, and any representative thereof.

Please also provide all such materials received by this agency’s Office of Public Affairs or equivalent division, and any representative thereof.

2. Related to all agency employees

Please also include all employee email communications containing the following phrases:

TALKING POINTS
STMT
STATEMENT
PRESS STRATEGY

Alternative Response to 2:

If processing of this portion of this request would require its distribution to another or multiple other offices, it would be greatly appreciated if a response to this request would contain a description of the necessary offices to be tasked, the process by which the search will be conducted, and an estimate of the time and fees to be incurred. Such a description will allow us to better understand the parameters of this FOIA office’s ability to respond to this request as worded and will better enable us to reorganize and limit it as appropriate.

-----

Additional clarification:

This request is not intended for materials regarding one particular subject or event during this period.

If a different search procedure will be required dependent on segment of time covered, it would be greatly appreciated if a response could contain a description of the necessary difference in approach by time period (for example, if file keeping procedures have changed at some point in the last year and a half or if particular materials have been moved to another location).
_________

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Beryl Lipton

From: Food and Drug Administration

Good afternoon,

Please fax this in to our office at 301-827-9267 or use our online form on FDA’s website. We are unable to process these through email, so please do not send by email.

Thank you,

Wilson M. Russ
Program Support Specialist
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8981
wilson.russ@fda.hhs.gov<mailto:wilson.russ@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

[cid:image002.jpg@01D1C57E.DFA022A0]<https://www.facebook.com/FDA> [cid:image003.jpg@01D1C57E.DFA022A0] <https://twitter.com/US_FDA> [cid:image004.jpg@01D1C57E.DFA022A0] <http://www.youtube.com/user/USFoodandDrugAdmin> [cid:image005.jpg@01D1C57E.DFA022A0] <http://www.flickr.com/photos/fdaphotos/> [cid:image006.jpg@01D1C57E.DFA022A0] <http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm>

From: Beryl Lipton

To Whom It May Concern:

This is a request under the Freedom of Information Act. I hereby request the following records:

For the 16-month, 5-day period from Tuesday, November 8, 2016 through Tuesday, March 13, 2018:

(SUMMARY)

Any and all talking points and similar memorandums, emails, and transcripts providing advice or direction on how to handle the media, media interviews, and statements.

----
(SPECIFICALLY)

Please include in your responsive materials any documents, emails, or communications with the following phrases in the title or subject line:

TALKING POINTS
STMT
STATEMENT
PRESS STRATEGY
___________

It would be greatly appreciated if materials could be provided on a rolling basis.

1. In the Office of Public Affairs or equivalent division

Please provide first all such materials produced in this agency’s Office of Public Affairs or equivalent division, and any representative thereof.

Please also provide all such materials received by this agency’s Office of Public Affairs or equivalent division, and any representative thereof.

2. Related to all agency employees

Please also include all employee email communications containing the following phrases:

TALKING POINTS
STMT
STATEMENT
PRESS STRATEGY

Alternative Response to 2:

If processing of this portion of this request would require its distribution to another or multiple other offices, it would be greatly appreciated if a response to this request would contain a description of the necessary offices to be tasked, the process by which the search will be conducted, and an estimate of the time and fees to be incurred. Such a description will allow us to better understand the parameters of this FOIA office’s ability to respond to this request as worded and will better enable us to reorganize and limit it as appropriate.

-----

Additional clarification:

This request is not intended for materials regarding one particular subject or event during this period.

If a different search procedure will be required dependent on segment of time covered, it would be greatly appreciated if a response could contain a description of the necessary difference in approach by time period (for example, if file keeping procedures have changed at some point in the last year and a half or if particular materials have been moved to another location).
_________

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Beryl Lipton

From: Food and Drug Administration

An interim response, stating the request is being processed.

From: Food and Drug Administration

Good afternoon.

I am contacting you regarding the status of your pending FOIA request (attached). I am currently reviewing your records and hope to have them completed soon.

Feel free to contact me directly with any concerns you may have regarding your request.

Kind regards,

Celeste Smith
Government Information Specialist
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8991
celeste.smith@fda.hhs.gov<mailto:celeste.smith@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

From: Food and Drug Administration

Good morning. I inadvertently attached the wrong request. The correct request is attached to this email.

Kind regards,

Celeste

From: Food and Drug Administration

Good morning. Attached are the redacted responsive records pertaining to your request. Also attached is a copy of your incoming request and the final Agency response.

You may contact me directly with any concerns you have regarding this release.

Kind regards,

Celeste Smith
Government Information Specialist
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8991
celeste.smith@fda.hhs.gov<mailto:celeste.smith@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

From: Beryl Lipton

Hello Ms. Smith,

Thank you so much for these materials! I'll let you know if I have any questions.

Best wishes,
Beryl

Files

pages

Close